MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

As the crypto market continues to grow in 2025, investors are eagerly searching for the best crypto to buy now. Among the ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...

MEI Pharma launched a $100 million Litecoin treasury strategy with backing from GSR, Titan Partners, and the Litecoin Foundation. Litecoin creator Charlie Lee joined MEI’s board, marking a rare ...

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (the “Company” or “MEI”) today announced that it has entered into securities purchase agreements for a private investment in public equity ...